Akash B. Gadani, MD: The Importance of Diet for GERD


Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.

Diet is an important component to treating gastrointestinal diseases, including gastroesophageal reflux disease (GERD).

However, while treatment adherence is often followed, adherence to new diets can be challenging because that could sometimes involve a complete lifestyle change.

And patients might be too resistant to radical dietary changes.

In an interview with HCPLive®, Akash B. Gadani, MD, Gastroenterology, Allegheny Health Network (AHN), said his advice on diet is often not for major changes to the types of food the patient is eating to reducing portion sizes.

“I find more in adjusting the amount you eat and when you eat as opposed to what you eat,” Gadani said. “I think patients are more receptive to that. If I try to limit someone’s diet it is counterproductive sometimes.”

Another suggestion for patients with GERD is not to eat too close to bedtime because when you are laying down, gravity is unable to move things along appropriately.

One of the challenges when prescribing a specific diet for GERD is there are different triggers for different patients. For example, while coffee might be a trigger for acid to 1 patient, chocolate might be the trigger for another.

“It is really difficult for me to predict what might be the trigger for you,” Gadani said. “Unfortunately it is more of a guess and test type of scenario.”

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.